New Search

If you are not happy with the results below please do another search

2034 search results for:

231

MEDICA 2022 and COMPAMED 2022: International health industry meet-up in Düsseldorf

Notable increase in participation – accompanying programme with many highlights and many prominent visitors Next week sees the return of the date marked in extra thick outline in many yearly calendars of the international health and medical technology industry: From Monday to Thursday (14 to 17 November 2022), the international leading medical trade fair MEDICA […]

232

Profiling of fatty sweet molecules on cell surfaces

Glycolipids, basically “fatty sweet” molecules, are a relatively unknown group of lipids. A new method developed by an Austrian team led by chemist Evelyn Rampler of the University of Vienna has now provided deeper insights into the functioning of certain glycolipids located on the surfaces of stem cells. The approach presented by the researchers from […]

233

Biochemists find substance that makes cancer cells “suicidal”

The Peoples’ Friendship University of Russia (RUDN) biochemists have obtained a potential anti-cancer agent. The new substance pro-vokes cancer cells to commit “suicide” and at the same time does not affect healthy cells. The results are published in Molecules [1].

235

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]

237

Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.

239

Greiner Bio-One achieves good results with sustain­ability assessment

Greiner Bio-One had its sustainability efforts evaluated for the first time for the entire Group through the EcoVadis platform and was awarded the silver medal for its commitment. The Greiner Bio-One Group achieved 60 out of 100 points. With this overall rating, the company group ranks among the top 20% of all companies evaluated. Greiner […]

240

Sphere Fluidics opens new lab facilities at Granta Park, UK

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.